Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rho GTPase activating protein 42 pseudogene 5 (ARHGAP42P5)
- Target
- ARHGAP42P5
- Molecular classification
- Other (Pseudogene)
01
Overview
ARHGAP42 pseudogene 5 (ARHGAP42P5) is a human pseudogene mapped to chromosome 14q11.2. It shares sequence similarity with the functional gene ARHGAP42, which encodes a Rho GTPase-activating protein involved in regulating RhoA activity, vascular tone, and blood pressure. However, ARHGAP42P5 is annotated as a pseudogene, meaning it does not encode a functional protein product and is generally non-functional. There are no known biological, clinical, or pharmacological roles attributed to ARHGAP42P5. Queries considering ARHGAP42P5 as an active therapeutic target or protein are incorrect and should refer instead to ARHGAP42 if investigating functional protein biology.
- Other names
- Rho GTPase activating protein 42 pseudogene 5
02
Mechanism of action
None (No known mechanisms of drug action for ARHGAP42P5)
03
Biological functions
None (pseudogenes do not have assigned biological functions unless regulatory functions have been described; no evidence for such function here)
04
Disease associations
None (No known disease association for ARHGAP42P5; unlike its parent ARHGAP42)
05
Safety considerations
None (No safety concerns or therapeutic challenges identified)
06
Interacting drugs
None (No drugs interact with ARHGAP42P5 as it is not a functional protein)
07
Biomarkers
None (Not used as a clinical biomarker)
Beyond the preview
Go deeper on Rho GTPase activating protein 42 pseudogene 5 (ARHGAP42P5).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rho GTPase activating protein 42 pseudogene 5 (ARHGAP42P5).